JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BHR
5251
Braemar Hotels & Resorts
BHR
$114M
| $203K | ﹤0.01% |
67,752
+37,403
| +123% | +$121K |
2013 Q4
44 quarters
|
|
5252
TScan Therapeutics
TCRX
$21.7M
| $203K | ﹤0.01% |
66,756
+34,951
| +110% | +$158K |
2023 Q4
4 quarters
|
|
5253
Innovator US Small Cap Power Buffer ETF October
KOCT
$130M
| $202K | ﹤0.01% |
6,623
-13,338
| -67% | -$412K |
2024 Q3
1 quarter
|
|
5254
Critical Metals Corp
CRML
$1.03B
| $202K | ﹤0.01% |
29,797
+17,753
| +147% | +$119K |
2024 Q1
3 quarters
|
|
5255
BK Technologies
BKTI
$286M
| $202K | ﹤0.01% |
5,891
+1,380
| +31% | +$42.1K |
2023 Q3
5 quarters
|
|
5256
AllianzIM U.S. Equity Buffer20 Aug ETF
AUGW
$127M
| $202K | ﹤0.01% |
6,894
+4,639
| +206% | +$135K |
2024 Q3
1 quarter
|
|
5257
CALL
Affirm
AFRM
$23.9B
| $201K | ﹤0.01% |
+3,300
| New | +$183K |
2024 Q4
0 quarters
|
|
5258
ProShares K-1 Free Crude Oil Strategy ETF
OILK
$230M
| $200K | ﹤0.01% |
4,532
+360
| +9% | +$15.6K |
2022 Q3
9 quarters
|
|
5259
Innovator US Equity Accelerated 9 Buffer ETF April
XBAP
$128M
| $200K | ﹤0.01% |
5,855
+4,222
| +259% | +$143K |
2024 Q2
2 quarters
|
|
|
DECM
5260
FT Vest U.S. Equity Max Buffer ETF - December
DECM
$36M
| $200K | ﹤0.01% |
+6,491
| New | +$200K |
2024 Q4
0 quarters
|
|
|
CMBT
5261
CMB.TECH NV
CMBT
$5.76B
| $199K | ﹤0.01% |
20,044
+15,692
| +361% | +$203K |
2022 Q1
11 quarters
|
|
|
XHYH
5262
DELISTED
BondBloxx USD High Yield Bond Healthcare Sector ETF
XHYH
| $198K | ﹤0.01% |
5,700
-3,922
| -41% | -$138K |
2024 Q2
2 quarters
|
|
5263
Orchestra BioMed
OBIO
$358M
| $198K | ﹤0.01% |
49,405
+38,535
| +355% | +$207K |
2023 Q2
6 quarters
|
|
|
SWKH
5264
DELISTED
SWK Holdings
SWKH
| $196K | ﹤0.01% |
15,586
+7,878
| +102% | +$102K |
2022 Q2
10 quarters
|
|
5265
iShares Interest Rate Hedged Long-Term Corporate Bond ETF
IGBH
$247M
| $195K | ﹤0.01% |
8,036
-508
| -6% | -$12.4K |
2024 Q3
1 quarter
|
|
5266
PUT
Gogo Inc
GOGO
$286M
| $195K | ﹤0.01% |
24,100
-197,300
| -89% | -$1.47M |
2024 Q2
2 quarters
|
|
5267
CALL
Amphenol
APH
$214B
| $194K | ﹤0.01% |
5,600
| – | – |
2024 Q3
1 quarter
|
|
|
AMPS
5268
DELISTED
Altus Power
AMPS
| $193K | ﹤0.01% |
47,489
+436
| +0.9% | +$1.59K |
2022 Q1
11 quarters
|
|
|
VZLA
5269
Vizsla Silver
VZLA
$1.28B
| $193K | ﹤0.01% |
112,844
-7,156
| -6% | -$13.7K |
2024 Q3
1 quarter
|
|
5270
Celcuity
CELC
$3.53B
| $192K | ﹤0.01% |
14,683
+2,676
| +22% | +$37.8K |
2022 Q4
8 quarters
|
|
5271
Direxion Auspice Broad Commodity Strategy ETF
COM
$218M
| $192K | ﹤0.01% |
+6,770
| New | +$195K |
2024 Q4
0 quarters
|
|
|
ECO
5272
Okeanis Eco Tankers
ECO
$3.41B
| $191K | ﹤0.01% |
9,006
-21,825
| -71% | -$560K |
2023 Q4
4 quarters
|
|
5273
CALL
Pinterest
PINS
$10.9B
| $191K | ﹤0.01% |
6,600
-44,300
| -87% | -$1.39M |
2024 Q1
3 quarters
|
|
|
YI
5274
111 Inc
YI
$28.3M
| $191K | ﹤0.01% |
30,604
+30,534
| +43,620% | +$238K |
2020 Q2
18 quarters
|
|
|
ZKH
5275
ZKH Group
ZKH
$432M
| $190K | ﹤0.01% |
54,243
+1,604
| +3% | +$5.85K |
2024 Q2
2 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.